Type 2 diabetes mellitus and cardiovascular disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Research topics (1), type 2 diabetes and the impact of TCM differences on the short-term and long-term prognosis of secondary ACS in patients with SCAD Inclusion criteria: ? age = 18 years; ? the first diagnosis in line with stable coronary heart disease patients; ? in line with the syndrome differentiation criteria of TCM; ? outpatient follow-up time = 12 months; ? voluntary participation in this study and signed informed consent. Research subjects (2), ACS patients with new diabetes after PCI risk factor analysis and integrated traditional Chinese and western medicine risk prediction model establishment inclusion criteria: ? age = 18 years; ? the first diagnosis in line with acute coronary syndrome (including unstable angina, acute myocardial infarction); ? in line with the diagnostic criteria of blood stasis syndrome in traditional Chinese medicine; ? accept the first coronary stent implantation; ? outpatient follow-up time = 12 months; ? voluntary participation in this study.
Exclusion criteria
Exclusion criteria: Study subjects (1) The impact of type 2 diabetes and TCM differences on the short-term and long-term prognosis of secondary ACS in patients with SCAD Exclusion criteria: (1) Patients who have undergone cardiac bypass; (2) Patients with severe liver and kidney dysfunction; (3) Patients with severe heart disease other than coronary artery disease, menstrual disease, cancer, pregnancy, perioperative hemodynamic instability; (4) Patients with acute metabolic disorders such as diabetic ketoacidosis and serious complications such as infection in the past 1 month; (5) Patients participating in other clinical trials. Research subjects (2) ACS patients with new diabetes after PCI risk factor analysis and integrated traditional Chinese and western medicine risk prediction model establishment exclusion criteria: (1) patients who have undergone cardiac bypass; (2) PCI treatment before the history of diabetes, hypoglycemic agents (or insulin) medication history, fasting blood glucose greater than 7.0 mmol/l, glycosylated hemoglobin = 6.5%; (3) with severe liver and kidney dysfunction; (4) with Alzheimer's disease, mental illness or depression; (5) after PCI did not take coronary heart disease secondary drugs; (6) participate in clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| LDL cholesterol;cholesterol;Glycosylated hemoglobin;Fasting plasma glucose;triglycerides; | — |
Countries
CHINA